A detailed history of Northern Trust Corp transactions in Novo Nordisk A S stock. As of the latest transaction made, Northern Trust Corp holds 3,649,765 shares of NVO stock, worth $441 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
3,649,765
Previous 3,529,709 3.4%
Holding current value
$441 Million
Previous $453 Million 14.95%
% of portfolio
0.09%
Previous 0.08%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$122.71 - $146.91 $14.7 Million - $17.6 Million
120,056 Added 3.4%
3,649,765 $521 Million
Q1 2024

May 14, 2024

SELL
$102.11 - $135.92 $629,814 - $838,354
-6,168 Reduced 0.17%
3,529,709 $453 Million
Q4 2023

Feb 13, 2024

SELL
$87.78 - $105.45 $4.35 Million - $5.22 Million
-49,530 Reduced 1.38%
3,535,877 $366 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $171 Million - $375 Million
1,881,264 Added 110.39%
3,585,407 $326 Million
Q2 2023

Aug 11, 2023

SELL
$155.98 - $172.65 $2.07 Million - $2.29 Million
-13,276 Reduced 0.77%
1,704,143 $276 Million
Q1 2023

May 15, 2023

SELL
$132.34 - $159.14 $21.2 Million - $25.5 Million
-160,341 Reduced 8.54%
1,717,419 $273 Million
Q4 2022

Feb 13, 2023

SELL
$102.55 - $135.33 $5.37 Million - $7.08 Million
-52,317 Reduced 2.71%
1,877,760 $254 Million
Q3 2022

Nov 14, 2022

SELL
$95.28 - $116.93 $3.23 Million - $3.97 Million
-33,922 Reduced 1.73%
1,930,077 $192 Million
Q2 2022

Aug 12, 2022

BUY
$103.24 - $121.81 $15.3 Million - $18 Million
148,063 Added 8.15%
1,963,999 $219 Million
Q1 2022

May 13, 2022

BUY
$93.1 - $112.54 $41.9 Million - $50.7 Million
450,122 Added 32.96%
1,815,936 $202 Million
Q4 2021

Feb 08, 2022

BUY
$95.88 - $117.08 $16.4 Million - $20 Million
171,161 Added 14.33%
1,365,814 $153 Million
Q3 2021

Nov 15, 2021

SELL
$84.42 - $106.62 $46 Million - $58.1 Million
-544,775 Reduced 31.32%
1,194,653 $115 Million
Q2 2021

Aug 13, 2021

SELL
$67.66 - $84.76 $18.7 Million - $23.5 Million
-276,999 Reduced 13.74%
1,739,428 $146 Million
Q1 2021

May 12, 2021

SELL
$67.06 - $75.82 $7.98 Million - $9.03 Million
-119,037 Reduced 5.57%
2,016,427 $136 Million
Q4 2020

Feb 11, 2021

SELL
$63.89 - $73.8 $677,425 - $782,501
-10,603 Reduced 0.49%
2,135,464 $149 Million
Q3 2020

Nov 16, 2020

SELL
$63.69 - $70.22 $410,545 - $452,638
-6,446 Reduced 0.3%
2,146,067 $149 Million
Q2 2020

Aug 14, 2020

SELL
$58.54 - $67.94 $4.95 Million - $5.75 Million
-84,591 Reduced 3.78%
2,152,513 $141 Million
Q1 2020

May 14, 2020

SELL
$49.46 - $64.78 $3.27 Million - $4.28 Million
-66,061 Reduced 2.87%
2,237,104 $135 Million
Q4 2019

Feb 14, 2020

BUY
$49.86 - $58.26 $796,064 - $930,179
15,966 Added 0.7%
2,303,165 $133 Million
Q3 2019

Nov 13, 2019

BUY
$47.54 - $53.43 $91,752 - $103,119
1,930 Added 0.08%
2,287,199 $118 Million
Q2 2019

Aug 13, 2019

SELL
$46.79 - $52.47 $2.13 Million - $2.39 Million
-45,579 Reduced 1.96%
2,285,269 $117 Million
Q1 2019

May 13, 2019

BUY
$46.36 - $52.63 $531,146 - $602,981
11,457 Added 0.49%
2,330,848 $122 Million
Q4 2018

Feb 12, 2019

BUY
$41.54 - $47.25 $6.17 Million - $7.01 Million
148,443 Added 6.84%
2,319,391 $107 Million
Q3 2018

Nov 14, 2018

BUY
$46.76 - $51.24 $3.63 Million - $3.98 Million
77,704 Added 3.71%
2,170,948 $102 Million
Q2 2018

Sep 18, 2018

SELL
$44.29 - $50.42 $5.54 Million - $6.31 Million
-125,117 Reduced 5.64%
2,093,244 $96.5 Million
Q2 2018

Aug 14, 2018

BUY
$44.29 - $50.42 $7.57 Million - $8.61 Million
170,842 Added 8.34%
2,218,361 $102 Million
Q1 2018

May 09, 2018

BUY
$48.49 - $58.14 $1.34 Million - $1.6 Million
27,532 Added 1.36%
2,047,519 $101 Million
Q4 2017

Feb 14, 2018

BUY
$47.53 - $53.73 $718,653 - $812,397
15,120 Added 0.75%
2,019,987 $108 Million
Q3 2017

Nov 13, 2017

BUY
$41.15 - $49.22 $82.5 Million - $98.7 Million
2,004,867
2,004,867 $96.5 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $273B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.